One of the three R's is under scrutiny
Sen. Marco Rubio (R-Fla.) and Rep. Tim Griffin (R-Ark.) are introducing bills in the Senate and House to repeal the rule under the Affordable Care Act (ACA) that creates risk corridors in the exchange marketplaces.
Even though insurers themselves contribute to the fund that helps equalize risk during start-up years, the lawmakers believe the government’s share is a burden on tax payers and they have some support, according to The Hill.
While risk adjustment is a permanent feature in the exchanges, risk corridors and the reinsurance mechanism are temporary and help prevent the so-called “death spiral,” which could drive an insurer out of market if it ended up with a disproportionate share of high-risk enrollees.
"The ACA's risk management programs are intended to protect consumers by helping to create a stable marketplace environment during the initial years of the law's implementation,” Clare Krusing, spokesperson for America’s Health Insurance Plans, tells MHE.
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More
Talking PIE, the Act, Before Thanksgiving
November 23rd 2022AMCP CEO Susan A. Cantrell spoke with Managed Healthcare Executive® about Preapproval Information Exchange (PIE) Act of 2022, which would allow drug manufacturers to share information about a drug with payers before the drug is approved. Cantrell says passage of the PIE Act would speed up patient access to new medications.
Read More
Inflation Reduction Act and the Impact on Pharmaceutical Pricing and Investment Decisions
November 21st 2022The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Read More